Skip to Main Content
Skip Nav Destination

Editorial Board

Editor-in-Chief

Aung Naing, MD, FACP
Professor, Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Editorial Board Members

Michael B. Atkins, MD
Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center; Professor and Vice-Chair, Department of Oncology, Georgetown University Medical Center, Washington, DC, USA

Karen Autio, MD, MSc
Assistant Attending, Genitourinary Oncology Service and Early Drug Development Service, Memorial Sloan Kettering Cancer Center, New York, NY

Jyoti Bajpai, MD
Professor, Department of Medical Oncology, Tata Memorial Centre, Parel, Mumbai, India

Mehmet Asim Bilen, MD
Associate Professor and Director, Genitourinary Medical Oncology Program, Emory University, Atlanta, GA, USA

Helen Chen, MD
Senior Investigator and Medical Officer, Associate Chief, Investigational Drug Branch, Cancer Therapy Evaluation Program (CTEP), National Cancer Institute, Bethesda, MD, USA

Naval Daver, MD
Associate Professor, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Gerald Falchook, MD, MS
Director, Drug Development Unit, Sarah Cannon Research Institute at HealthONE, Denver, CO, USA

Angela G. Fleischman, MD, PhD
Associate Professor, Division of Hematology/Oncology, University of California, Irvine, Irvine, CA, USA

Aaron Goodman, MD
Associate Professor, Division of Blood and Marrow Transplantation, University of California, San Diego School of Medicine, San Diego, CA, USA

Joud Hajjar, MD, MS
Assistant Professor and Service Chief of Adult Allergy and Immunology, Division of Immunology, Allergy, and Rheumatology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA

Rebecca Harrison, MD
BC Cancer, Vancouver, British Columbia

Sungjune Kim, MD, PhD
Departments of Radiation Oncology and Immunology, H. Lee. Moffitt Cancer Center & Research Institute; Assistant Professor, Department of Oncologic Sciences, University of South Florida, Tampa, FL, USA

Matthew Krebs, MD
Clinical Senior Lecturer, Division of Cancer Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester; Consultant in Medical Oncology, Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK

Vladimir Lazar, MD, PhD
Chief Scientific and Operating Officer, Worldwide Innovative Network (WIN) Association - WIN Consortium, Villejuif, France

Yisheng Li, PhD
Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Chia-Chi Lin, MD, PhD
Director of Phase 1 Center, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan

Sewanti Limaye MS, MBBS, MD
Department of Clinical and Translational Research Oncology, Department of Precision Oncology, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, India

Sanam Loghavi, MD
Assistant Professor, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Herbert Loong, MD
Clinical Associate Professor, Department of Clinical Oncology; Deputy Medical Director, Phase 1 Clinical Trials Centre, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China

Juanita Lopez, MD
Consultant in Medical Oncology, Drug Development Phase 1 Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, UK

Christophe Massard, MD
Department of Drug Development (DITEP), Gustave Roussy, Villejuif, France; Centre Eugène Marquis, Rennes, France; INSERM U1030, Université Paris-Saclay, Gif-sur-Yvette, France 

Gil Morgan, MD
Department of Oncology, Skåne University Hospital, Lund, Sweden

Paolo Nuciforo, MD
Principal Investigator, Molecular Oncology Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital, Barcelona, Spain

Haeseong Park, MD MPH
Co-Director, Developmental Therapeutics (Phase I) Program, Division of Oncology, Alvin J Siteman Cancer Center, Washington University in Saint Louis, St. Louis, MO, USA

Naveen Pemmaraju, MD
Associate Professor, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Bradford Perez, MD
Department of Radiation Oncology, H. Lee. Moffitt Cancer Center & Research Institute, Tampa, FL, USA

Jordi Rodon Ahnert, MD
Associate Professor, Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Christina L. Roland, MD, MS, FACS
Assistant Professor of Surgery, Vice Chair of Research, Department of Surgical Oncology, Chief of Sarcoma Section, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Christian Rolfo, MD
Associate Director of Clinical Research, Center for Thoracic Oncology, The Tisch Cancer Institute, Mount Sinai Health System; Professor, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Patricia Roxburgh, MD
Senior Clinical Lecturer, Experimental Therapeutics, Institute of Cancer Sciences, University of Glasgow; Beatson West of Scotland Cancer Centre, Glasgow, Scotland, UK

Erika Ruíz-García, MD, MCs
Department Gastrointestinal Medical Oncology, Chief of Translational Medicine Laboratory. Instituto Nacional de Cancerologia (INCan), Mexico City, Mexico

Nina Niu Sanford, MD
Assistant Professor, Department of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA

Ajay Sheshadri, MD
Assistant Professor, Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Richard Simon, D. Sc.
R Simon Consulting, Potomac, MD, USA

Bettzy Stephen, MD
Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Shannon N. Westin, MD, MPH, FACOG
Director, Early Drug Development, Gynecologic Oncology and Reproductive Medicine, The University of Texas UT MD Anderson Cancer Center, Houston, TX, USA

Eddy Yang, MD, PhD
Deputy Director and Associate Director for Precision Oncology, Hugh Kaul Precision Medicine Institute; Program Co-Leader, Experimental Therapeutics, O’Neal Comprehensive Cancer Center; Professor and Vice Chair for Translational Sciences, Department of Radiation Oncology, University of Alabama, Birmingham, AL, USA

Close Modal

or Create an Account

Close Modal
Close Modal